SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Oxford GlycoSciences Plc
An SI Board Since January 2000
Posts SubjectMarks Bans
469 13 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
219OXFORD, England, June 24 /PRNewswire-FirstCall/ -- Oxford GlycoSciences Plc (Nasnigel bates-6/24/2002
218<i>Oxford GlycoSciences Plc is pleased to announce the appointment of Davinigel bates-5/24/2002
217OGS appoints new Chief Executive Officer Oxford, UK, 23 May 2002 -- Oxford Glycnigel bates-5/23/2002
216This article on "glycomics" and the Human Glycome Project would appeartuck-5/7/2002
215PRAGUE, Czech Republic, May 2 /PRNewswire-FirstCall/-- Oxford GlycoSciences Plc nigel bates-5/2/2002
214<i>Only another 12% downside</i> For a BT, 12% either way is virtuakeokalani'nui-4/24/2002
213<i>Only another 12% downside...</i> Thanks for the reassurance. <nigel bates-4/24/2002
212Good price for it now. No doubt. Only another 12% downside if V fails altogethkeokalani'nui-4/24/2002
211OXFORD, UK, April 24 /PRNewswire-FirstCall/ -- Oxford GlycoSciences Plc (LSE: OGnigel bates-4/24/2002
210Oxford Glycosciences PLC 24 April 2002 SCHEDULE 10 NOTIFICATION OF MAJOR INTERnigel bates-4/24/2002
209Article on the Confirmant effort, and why its protein atlas is better than most tuck-4/9/2002
208We may hear something more next month ? ogs.com EWGGD (European Working Group onigel bates-4/2/2002
207Wilder, I listened to the presentation and looked at the slides. The slides artuck-3/29/2002
206Just for the purpose of dialogue... Failure has not been entirely priced in. Akeokalani'nui-3/29/2002
205Links backing my prior post . . . Here's one concerning the types of Gautuck-3/29/2002
204Nigel, In poking around Gaucher's websites, I notice that neurological probtuck-3/28/2002
203I sold 1/3 of my ogsi today for a nasty little loss. Wilderkeokalani'nui-3/25/2002
202OXFORD, UK, March 21 /PRNewswire-FirstCall/ -- Oxford GlycoSciences Plc (LSE: OGnigel bates-3/21/2002
201LONDON, March 21 (Reuters) - Shares in Oxford GlycoSciences (LSE: OGS.L - news) nigel bates-3/21/2002
200<i>didnt knew crucell had enuf cash...</i> Hey, it's only a newnigel bates-3/18/2002
199Dutch company Crucell... didnt knew crucell had enuf cash to pay my shares in Odalroi-3/18/2002
198From The Sunday Business - <i>Biotech group Oxford Glycosciences (LSE: OGnigel bates-3/18/2002
197Pretty good day in the UK - Last Trade 17:36 · 430.00 p Change +50.0nigel bates-3/14/2002
196OGS and BioInvent form Therapeutic Antibodies Alliance OXFORD, UK and LUND, Swenigel bates-3/14/2002
195<i>for personal family reasons</i> Apparently he (& his family)nigel bates-3/11/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News